MediPoint: Hernia Repair - APAC Analysis and Market Forecasts

Summary

Dramatic improvements in access to and quality of healthcare in the Asia Pacific region, concurrent with the introduction of next-generation biologic and composite meshes in developed countries and adoption of laparoscopic techniques worldwide, will drive hernia repair market growth in the US, Europe and Asia Pacific. Saturated with numerous players and a library of different products, the fiercely-competitive hernia mesh industry has experienced notable improvements recently in device quality and affordability, as companies strive for increased physician adoption in established markets and strategize entry into new regions.

The report provides a comprehensive evaluation of the global hernia market, including development and sales of inguinal, incisional and umbilical hernia repair products. Included within is an analysis of the drivers, opportunities and barriers impacting growth in the mesh market worldwide, with in-depth breakdown by surgical technique to highlight the fast adoption of laparoscopic methods. The report identifies and evaluates key trends and unmet needs shaping the global market through 2019, emphasizing testimonials from top physicians around the world who are implanting the devices.

GlobalData estimates the overall hernia repair market in the APAC region in 2012 to be $1.011 billion across the three countries covered (Japan, China, and India). While the developed economies of Japan and the United States occupy a large proportion of the global hernia repair market, it is the developing nation of India that occupies nearly a third of the global market.

GlobalData built this report using data and information sourced from secondary sources, as well as primary research interviews with leading Herniologists and General Surgeons around the world, and in-house analysis conducted by GlobalData’s team of industry experts.

Scope

- An overview of hernia, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
- Annualized APAC hernia repair market revenue and future forecasts from 2009 to 2011, forecast for 7 years to 2018.
- Investigation of current and future market competition for hernia repair
- Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
- Competitor assessment including device approval analysis and device sales forecasts.
- Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
- Analysis of unmet needs within the market and opportunities for future players.
- Technology trends evaluation to assess strength of pipeline.
- An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.
- Company profiles including business description, financial overview and SWOT analysis.
- Coverage of key market players.
- Strategic assessment of the hernia repair sector through market impact analysis, future market scenario and company analysis.
- Direct quotes from Key Opinion Leaders (KOL) as well as herniologists

Reasons to buy

- Understand the trends shaping and driving the APAC hernia repair Market.
- Realize device preferences of physicians who have performed the tests already.
- Access market sizing, forecasts and quantified growth opportunities in the APAC hernia repair market through 2018.
- Quantify candidate patient populations to better design product pricing & launch plans.
- Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
- Perform benchmarking analysis of growth opportunities against currently marketed products.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Take a comprehensive look at the market’s device pipeline and identify promising, paradigm-shifting products.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
- What’s the next big thing in APAC hernia repair market landscape? Identify, understand and capitalize.

Table Of Contents

1 Table of Contents
1 Table of Contents 6


2 Introduction 20
2.1 Catalyst 21
3 Disease Overview 22
3.1 Anatomy and Physiology 22
3.1.1 Inguinal Hernias 22
3.1.2 Incisional Hernias 24
3.1.3 Umbilical Hernias 25
3.2 Pathophysiology 26
3.2.1 Inguinal Hernia 26
3.2.2 Incisional Hernia 28
3.2.3 Umbilical Hernia 28
3.3 Clinical Presentation 29
3.3.1 Symptoms 29
3.3.2 Diagnosis 30
3.3.3 Clinical Outcomes 31
3.4 Epidemiology 35
3.4.1 Inguinal Hernias 36
3.4.2 Incisional Hernias 39
3.4.3 Umbilical Hernias 42
3.5 Economic Impact 44
3.5.1 Open versus Laparoscopic Repair 44
3.5.2 Watchful Waiting 45
3.5.3 APAC 46
4 Competitive Assessment 47
4.1 Overview 47
4.2 Large Pore Meshes 48
4.2.1 Overview 48
4.2.2 Angimesh R2 (Angiologica) 51
4.2.3 Assumesh (Assut Europe) 53
4.2.4 Cristalene (Abiss Analytical Biosurgical Systems) 54
4.2.5 Hexapro Mesh (Agency for Medical Innovation) 56
4.2.6 Optilene Mesh (B. Braun) 57
4.2.7 Omyra Mesh (B. Braun) 61
4.2.8 ProLite Ultra Mesh (Atrium Medical) 62
4.2.9 Surgimesh 1 and 2 and XLIGHT (Aspide Medical) 64
4.2.10 Surgimesh PET 2D (Aspide Medical) 65
4.2.11 Surgimesh WN (Aspide Medical) 67
4.2.12 Vypro Mesh (Ethicon) 69
4.3 Small Pore Meshes 71
4.3.1 Overview 71
4.3.2 Premilene Mesh (B. Braun) 73
4.3.3 Prolene Mesh (Ethicon) 76
4.3.4 ProLite Mesh (Atrium Medical) 78
4.3.5 Repol Angimesh (Angiologica) 79
4.4 Composite Meshes 81
4.4.1 Overview 81
4.4.2 4DDome (Cousin Biotech) 83
4.4.3 B-Foil (Assut Europe) 85
4.4.4 Biomesh CA.B.S Air Composite (Cousin Biotech) 86
4.4.5 C-QUR Mesh (Atrium Medical) 87
4.4.6 C-QUR TacShield (Atrium Medical) 88
4.4.7 C-QUR V-Patch (Atrium Medical) 90
4.4.8 C-QUR CentriFX (Atrium Medical) 91
4.4.9 C-QUR FX Mesh (Atrium Medical) 92
4.4.10 Parietex Composite (Covidien) 93
4.4.11 Parietex ProGrip Self Fixating Mesh (Covidien) 95
4.4.12 Sorbimesh (Assut Europe) 96
4.4.13 Surgimesh Cible (Aspide Medical) 97
4.4.14 Surgimesh Diablo (Aspide Medical) 99
4.4.15 Surgimesh M.O.P.P. (Aspide Medical) 100
4.4.16 Surgimesh XB (Aspide Medical) 102
4.4.17 Ultrapro Mesh (Ethicon) 104
4.5 3D Meshes 105
4.5.1 Overview 105
4.5.2 3DMax Mesh (C.R. Bard) 108
4.5.3 Bio-A Hernia Plug (W. L. Gore and Associates) 109
4.5.4 Laparomesh (Assut Europe) 111
4.5.5 Perfix Plug (C.R. Bard) 112
4.5.6 ProLoop Mesh (Atrium Medical) 114
4.5.7 Surgimesh Easyplug (Aspide Medical) 115
4.5.8 Surgimesh PET 3D (Aspide Medical) 118
4.5.9 Surgimesh XD (Aspide Medical) 119
4.5.10 Repol Plug Cap (Angiologica) 121
4.6 Biologic Hernia Meshes 122
4.6.1 Overview 122
4.6.2 AlloDerm Regenerative Tissue Matrix (LifeCell) 125
4.6.3 Allomax Surgical Graft (Davol) 127
4.6.4 Biodesign Hernia Graft (Cook Medical) 129
4.6.5 Permacol Surgical Implant (Covidien) 132
4.6.6 Strattice (LifeCell) 133
5 Unmet Needs 135
5.1 Overview 135
5.2 Specialized Laparoscopic Clinics 135
5.3 Increased investigation of TAPP versus TEP procedures 136
5.4 Competitive Pricing for Premium Hernia Meshes 137
5.5 Economic and Financial Impact of Laparoscopic Techniques 138
5.6 Research and Development of Self-Fixating Meshes 139
5.7 Registry for Laparoscopic Hernia Repair 140
6 Pipeline Products 142
6.1 Overview 142
6.2 Clinical Trial Analysis 143
6.2.1 Overview 143
6.2.2 Trials to Watch 144
7 Industry Overview 145
7.1 Procedure Trends 145
7.1.1 Japan 145
7.1.2 China 146
7.1.3 India 147
7.2 Market Access 148
7.2.1 Cost Concerns 148
7.2.2 Group Purchasing Organizations 149
7.2.3 Distribution Networks 149
7.2.4 Access to Healthcare 150
7.3 Reimbursement Trends 151
7.3.1 Overview 151
7.3.2 APAC 151
7.4 Regulatory Issues/Recalls 152
7.5 Added Indications 152
7.6 Mergers and Acquisitions/Key Partnerships 153
7.6.1 Baxter Acquires Synovis Life Technologies 153
7.6.2 Covidien Acquires Tissue Science Laboratories 153
8 Current and Future Players 154
8.1 Trends in Corporate Strategy 154
8.2 Company Profiles 155
8.2.1 Abiss Analytic Biosurgical Solutions 155
8.2.2 AMI: Agency for Medical Innovation 156
8.2.3 Angiologica 157
8.2.4 Aspide Medical 158
8.2.5 Assut Europe 160
8.2.6 Atrium Medical 161
8.2.7 B. Braun Surgical 162
8.2.8 Cook Medical 164
8.2.9 Cousin Biotech 165
8.2.10 Covidien 167
8.2.11 C.R. Bard 168
8.2.12 Ethicon 170
8.2.13 FEG Textiltechnik mbH 172
8.2.14 Proxy Biomedical 173
8.2.15 TEI Biosciences 174
8.2.16 W. L. Gore and Associates 175
9 Market Drivers and Opportunities 178
9.1 Market Drivers 178
9.1.1 Consistent Hernia Prevalence 178
9.1.2 Transition from Open Hernia Repair to Laparoscopic Hernia Repair 178
9.1.3 Fall of Watchful Waiting 180
9.1.4 Residents Being Trained on Laparoscopic Technique 182
9.2 Opportunities 183
9.2.1 Invest in Composite Meshes Designed Specifically for Laparoscopic Repair 183
9.2.2 Market Meshes to Specialized Centers 184
9.2.3 Focus on Countries Experiencing Increasing Composite Mesh Adoption 185
9.2.4 Develop Business Relationships with Robotic Surgery Equipment Manufacturers 186
9.3 Market Barriers 187
9.3.1 Group Purchasing Organizations 187
9.3.2 Reimbursement 188
9.3.3 Cost 189
9.3.4 Self-Gripping Technology 189
9.3.5 Mosquito Net Mesh 191
10 Country Outlooks and Forecasts 193
10.1 Japan 193
10.1.1 Overall Hernia Repair Market 193
10.1.2 Overall Inguinal Hernia Repair Market 194
10.1.3 Overall Incisional Hernia Repair Market 195
10.1.4 Overall Umbilical Hernia Repair Market 195
10.2 India 196
10.2.1 Overall Hernia Repair Market 196
10.2.2 Overall Inguinal Hernia Repair Market 197
10.2.3 Overall Incisional Hernia Repair Market 198
10.2.4 Overall Umbilical Hernia Repair Market 198
10.3 China 199
10.3.1 Overall Hernia Repair Market 199
10.3.2 Overall Inguinal Hernia Repair Market 200
10.3.3 Overall Incisional Hernia Repair Market 201
10.3.4 Overall Umbilical Hernia Repair Market 201
11 Appendix 202
11.1 Bibliography 202
11.2 Abbreviations 215
11.3 Report Methodology 216
11.3.1 Overview 216
11.3.2 Coverage 216
11.3.3 Primary Research 216
11.3.4 Secondary Research 217
11.3.5 Forecasting Methodology 218
11.4 General Surgeons and Herniologists Included in this Study 219
11.5 About the Authors 220
11.5.1 Joseph A. Gregory, Analyst, Surgical Devices 220
11.5.2 Derek Archila, MBA, Director of Research and Analysis, Medical Devices 220
11.6 Global Head of Healthcare 221
11.6.1 Bonnie Bain, Ph.D., Global Head of Healthcare 221
11.7 About MediPoint 222
11.8 About GlobalData 222
11.9 Disclaimer 222

1.1 List of Tables
Table 1: Layers of the Abdominal Wall 22
Table 2: Distribution by Sex in the Major Markets, 2012 36
Table 3: Inguinal Hernia, Distribution by Age in the Major Markets, 2012 37
Table 4: Hernia Mesh Classifications 47
Table 5: Large Pore SWOT Analysis, 2013 50
Table 6: Product Profile - Angimesh R2 52
Table 7: Product Profile - Assumesh 53
Table 8: Product Profile - Cristalene 55
Table 9: Product Profile - Hexapro Mesh 56
Table 10: Product Profile - Optilene Mesh 57
Table 11: Product Profile - Optilene Mesh LP 58
Table 12: Product Profile - Optilene Mesh Elastic 59
Table 13: Product Profile - Omyra Mesh 61
Table 14: Product Profile - ProLite Ultra Mesh 63
Table 15: Product Profile - Surgimesh 1 and 2 and XLIGHT 64
Table 16: Product Profile - Surgimesh PET 2D 66
Table 17: Product Profile - Surgimesh WN 68
Table 18: Product Profile - Vypro Mesh 70
Table 19: Small Pore SWOT Analysis, 2013 72
Table 20: Product Profile - Premilene Mesh 73
Table 21: Product Profile - Premilene Mesh Plug 74
Table 22: Product Profile - Prolene Mesh 77
Table 23: Product Profile - ProLite Mesh 78
Table 24: Product Profile - Repol Angimesh 80
Table 25: Composite Meshes SWOT Analysis, 2013 81
Table 26: Product Profile - 4DDome 84
Table 27: Product Profile - B-Foil 85
Table 28: Product Profile - Biomesh CA.B.S. Air Composite 87
Table 29: Product Profile - C-QUR Mesh 88
Table 30: Product Profile - C-QUR TacShield 89
Table 31: Product Profile - C-QUR V-Patch 90
Table 32: Product Profile - C-QUR CentriFX 91
Table 33: Product Profile - C-QUR FX Mesh 92
Table 34: Product Profile - Parietex Composite 94
Table 35: Product Profile - Parietex ProGrip Self Fixating Mesh 95
Table 36: Product Profile - Sorbimesh 97
Table 37: Product Profile - Surgimesh Cible 98
Table 38: Product Profile - Surgimesh Diablo 100
Table 39: Product Profile - Surgimesh M.O.P.P. 101
Table 40: Product Profile - Surgimesh XB 103
Table 41: Product Profile - Ultrapro Mesh 104
Table 42: 3D Meshes SWOT Analysis, 2013 106
Table 43: Product Profile - 3DMax Mesh 108
Table 44: Product Profile - Bio-A Hernia Plug 110
Table 45: Product Profile - Laparomesh 112
Table 46: Product Profile - Perfix Plug 113
Table 47: Product Profile - ProLoop FX Mesh 114
Table 48: Product Profile - Easyplug 117
Table 49: Product Profile - Surgimesh PET 3D 119
Table 50: Product Profile - Surgimesh XD 120
Table 51: Product Profile - Repol Plug Cap 121
Table 52: Biological Meshes SWOT Analysis, 2013 123
Table 53: Product Profile - AlloDerm Regenerative Tissue Matrix 126
Table 54: Product Profile - Allomax Surgical Graft 128
Table 55: Product Profile - Biodesign Hernia Graft 130
Table 56: Product Profile - Permacol Surgical Implant 132
Table 57: Product Profile - Strattice 133
Table 58: Overall Unmet Needs - Current Level of Attainment and Importance 135
Table 59: Company Portfolio - Abyss Analytic Biosurgical Solutions 155
Table 60: Abyss Analytic Biosurgical Solutions SWOT Analysis, 2013 156
Table 61: Company Portfolio - AMI: Agency for Medical Innovation 156
Table 62: AMI: Agency for Medical Innovation SWOT Analysis, 2013 157
Table 63: Company Portfolio - Angiologica 157
Table 64: Angiologica SWOT Analysis, 2012 158
Table 65: Company Portfolio - Aspide Medical 159
Table 66: Aspide Medical SWOT Analysis, 2013 159
Table 67: Company Portfolio - Assut Europe 160
Table 68: Assut Europe SWOT Analysis, 2013 160
Table 69: Company Portfolio - Atrium Medical 161
Table 70: Atrium Medical SWOT Analysis, 2013 162
Table 71: Company Portfolio - B. Braun 163
Table 72: B. Braun SWOT Analysis, 2012 164
Table 73: Company Portfolio - Cook Medical 164
Table 74: Cook Medical SWOT Analysis, 2013 165
Table 75: Company Portfolio - Cousin Biotech 166
Table 76: Cousin Biotech SWOT Analysis, 2013 166
Table 77: Company Portfolio - Covidien 167
Table 78: Covidien SWOT Analysis, 2013 168
Table 79: Company Portfolio - C. R. Bard 169
Table 80: C. R. Bard SWOT Analysis, 2013 170
Table 81: Company Portfolio - Ethicon 170
Table 82: Ethicon SWOT Analysis, 2013 171
Table 83: Company Portfolio - FEG Textiltechnik 172
Table 84: FEG Textiltechnik SWOT Analysis, 2013 173
Table 85: Company Portfolio - Proxy Biomedical 173
Table 86: Proxy Biomedical SWOT Analysis, 2013 174
Table 87: Company Portfolio - TEI Biosciences 174
Table 88: TEI Biosciences SWOT Analysis, 2013 175
Table 89: Company Portfolio - W. L. Gore and Associates 176
Table 90: W. L. Gore and Associates SWOT Analysis, 2012 177
Table 91: Laparoscopic Adoption Across the Major Markets, 2012 and 2019 179
Table 92: Composite Mesh Adoption in Inguinal Hernia Repair across Major Markets, 2012 and 2019 186
Table 93: Composite Mesh Adoption in Incisional Hernia Repair across Major Markets, 2012 and 2019 186
Table 94: Japan Hernia Mesh Repair Sales ($m) Forecast, 2010-2019 193
Table 95: India Hernia Mesh Repair Sales ($m) Forecast, 2010-2019 196
Table 96: China Hernia Mesh Repair Sales ($m) Forecast, 2010-2019 199

1.2 List of Figures
Figure 1: Inguinal Hernia 23
Figure 2: Layers of the Abdominal Wall 24
Figure 3: Anatomy of an Umbilical Hernia 25
Figure 4: Indirect Inguinal Hernia 26
Figure 5: Direct Inguinal Hernia 27
Figure 6: Entrance Points for Laparoscopic Inguinal Hernia Repair 34
Figure 7: Prevalence of Total Inguinal Hernias in APAC, 2010-2019 38
Figure 8: Prevalence of Total Incisional Hernias in APAC, 2010-2019 41
Figure 9: Prevalence of Total Umbilical Hernias in APAC, 2010-2019 43
Figure 10: Global Company Market Share, Large Pore Meshes, 2012 51
Figure 11: Structure of Angimesh R2 51
Figure 12: Structure of Assumesh 53
Figure 13: Structure of Cristalene 54
Figure 14: Structure of Hexapro Mesh 56
Figure 15: Structure of Optilene Mesh 57
Figure 16: Structure of Optilene Mesh LP 58
Figure 17: Structure of Optilene Mesh Elastic 59
Figure 18: Structure of Omyra Mesh 61
Figure 19: Structure of ProLite Ultra Mesh 62
Figure 20: Structure of Surgimesh 1 and 2 and XLIGHT 64
Figure 21: Structure of Surgimesh PET 2D 65
Figure 22: Structure of Surgimesh WN 67
Figure 23: Structure of Vypro Mesh 69
Figure 24: Global Company Market Share, Small Pore Meshes, 2012 72
Figure 25: Structure of Premilene Mesh 73
Figure 26: Structure of Premilene Mesh Plug 74
Figure 27: Structure of Prolene Mesh 76
Figure 28: Structure of ProLite Mesh 78
Figure 29: Structure of Repol Angimesh 79
Figure 30: Global Company Market Share, Composite Meshes, 2012 82
Figure 31: Structure of the 4DDome 83
Figure 32: Structure of B-Foil 85
Figure 33: Structure of the Biomesh CA.B.S. Air Composite 86
Figure 34: Structure of C-QUR Mesh 87
Figure 35: Structure of C-QUR TacShield 88
Figure 36: Structure of C-QUR V-Patch 90
Figure 37: Structure of C-QUR CentriFX 91
Figure 38: Structure of C-QUR FX Mesh 92
Figure 39: Structure of Parietex Composite 93
Figure 40: Structure of Parietex ProGrip Self Fixating Mesh 95
Figure 41: Structure of Sorbimesh 96
Figure 42: Structure of Surgimesh Cible 97
Figure 43: Structure of Surgimesh Diablo 99
Figure 44: Structure of Surgimesh M.O.P.P. 100
Figure 45: Structure of Surgimesh XB 102
Figure 46: Structure of Ultrapro Mesh 104
Figure 47: Global Company Market Share, Composite Meshes, 2012 107
Figure 48: Structure of the 3DMax Mesh 108
Figure 49: Structure of the Bio-A Hernia Plug 109
Figure 50: Structure of Laparomesh 111
Figure 51: Structure of Perfix Plug 112
Figure 52: Structure of ProLoop Mesh 114
Figure 53: Structure of Surgimesh Easyplug Standard 115
Figure 54: Structure of Surgimesh WN Easyplug 116
Figure 55: Structure of Surgimesh WN Easyplug No Touch 116
Figure 56: Structure of Surgimesh PET 3D 118
Figure 57: Structure of Surgimesh XD 119
Figure 58: Structure of Repol Plug Cap 121
Figure 59: Global Company Market Share, Biological Meshes, 2012 124
Figure 60: Structure of the AlloDerm Regenerative Tissue Matrix 126
Figure 61: Structure of the Allomax Surgical Graft 127
Figure 62: Structure of the Biodesign Hernia Graft 129
Figure 63: Structure of the Permacol Surgical Implant 132
Figure 64: Open versus Laparoscopic Procedure Volumes, Japan, 2010-2019 145
Figure 65: Open versus Laparoscopic Procedure Volumes, China, 2010-2019 146
Figure 66: Open versus Laparoscopic Procedure Volumes, India, 2010-2019 147
Figure 67: Japan Hernia Mesh Repair Sales ($m) Forecast, 2010-2019 194
Figure 68: India Hernia Mesh Repair Sales ($m) Forecast, 2010-2019 197
Figure 69: China Hernia Mesh Repair Sales ($m) Forecast, 2010-2019 200

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Analysis of the Global Infectious Disease Diagnostics Market

Analysis of the Global Infectious Disease Diagnostics Market

  • $ 10 000
  • Industry report
  • September 2014
  • by Frost & Sullivan

Molecular Methods Present Significant Opportunities This deliverable provides research and analysis of the global infectious disease diagnostics market. It includes an in-depth analysis of revenue forecast ...

OpportunityAnalyzer: Chronic Lymphocytic Leukemia - Opportunity Analysis and Forecasts to 2018

OpportunityAnalyzer: Chronic Lymphocytic Leukemia - Opportunity Analysis and Forecasts to 2018

  • $ 7 995
  • Industry report
  • June 2014
  • by Global Data

OpportunityAnalyzer: Chronic Lymphocytic Leukemia - Opportunity Analysis and Forecasts to 2018 Summary Chronic lymphocytic leukemia (CLL), the most common form of adult leukemia, is caused by the uncontrolled ...

Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation

Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation

  • $ 6 995
  • Industry report
  • July 2014
  • by GBI Research

Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation Summary Exceptionally Large and Innovative Pipeline The breast cancer pipeline is the largest in the pharmaceutical ...

Bcc Research Bitopertin Forecast

August 2014 $ 5 500

4 Companies

Company Profiles

SYNTHES Inc.

Switzerland

Biosense Webster Inc.

United States

Synthes Inc.

United States

Johnson and Johnson

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.